News
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer ...
Aug 25 (Reuters) - Royalty Pharma (RPRX.O), opens new tab has agreed to buy a royalty interest in Amgen's (AMGN.O), opens new tab drug for small cell lung cancer from BeOne Medicines (688235.SS), ...
BeOne Medicines is monetizing its stake in Amgen’s first-in-class lung cancer drug Imdelltra for up to $950 million. Royalty Pharma will pay BeOne $885 million upfront for certain royalty payments ...
Akeso, Summit's PD-1xVEGF drug meets overall survival goal for the first time in a lung cancer trial
For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend patients’ lives. A “statistically significant and clinically meaningful” ...
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...
The benefits of artificial intelligence (AI) in the medical space are ever-growing, but evidence suggests it can also come with risks. A new study by European researchers investigated how AI can ...
Eating more meat could be beneficial for the body, a new study suggests. Recent research from Canada’s McMaster University revealed that animal-sourced foods are not linked to a higher risk of death.
What we eat can affect our gut health and colon cancer risk. Dr. Neelendu Dey is a gastroenterologist who researches the relationship between gut health and colon cancer. To support his gut health, ...
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results